Kendall Moseley is an Endocrinology/Metabolic physician affiliated with Johns Hopkins University. OpenAlex indexes 50 publications with 1,233 citations (h-index 18).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingMedicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Hormonal (systemic)
56.5%l-Thyroxine28.1%Levothyroxine Sodium59%Synthroid41%Part D<11 patientsCalcium-sensing Receptor Agonist16.2%Cinacalcet Hcl73%Sensipar27%Part D<11 patients+ 2 more classes in this area
Metabolism & gastrointestinal
31.2%Vitamin D3 Analog15.4%Calcitriol100%Part D<11 patientsProvitamin D2 Compound11.1%Vitamin D2100%Part D<11 patients+ 1 more class in this area
Cardiovascular
7.9%Thiazide diuretic7.9%Hydrochlorothiazide100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
3 NIH research awards on record, funded 2011–2019 per NIH RePORTER. The latest:
- Skeletal survivorship and immune therapy: The effects of nivolumab on bone metabolism in renal cell carcinoma
Johns Hopkins University
FY2019$370,511R21AR073620 - Skeletal survivorship and immune therapy: The effects of nivolumab on bone metabolism in renal cell carcinoma
Johns Hopkins University
FY2018$205,311R21AR073620 - Defining and demystifying bone quality in type 2 diabetes mellitus
Johns Hopkins University
FY2016$185,706K23DK093720
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Roger Blumenthal, MD
Johns Hopkins University
Erin Michos, MD
Johns Hopkins University
Morgan Grams, MD
Johns Hopkins University
Mario Eisenberger, MD
Johns Hopkins University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”